We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8802:TSEMitsubishi Estate Company, Limited Analysis

Data as of 2026-03-10 - not real-time

¥4,913.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Mitsubishi Estate is trading at ¥4,913, just below its 20‑day SMA (¥4,982) but comfortably above the 50‑day (¥4,370) and 200‑day (¥3,435) averages, indicating a still‑bullish medium‑term trend. The stock enjoys a modest upside of ~8% to the 52‑week high of ¥5,407, supported by a strong earnings beat and FY25 profit guidance lift, plus an announced additional share buyback that has already spurred price gains. Fundamentally, revenue is expanding at 14.8% YoY with healthy operating (25.7%) and profit margins (13.8%), while the PE of 31 sits below the industry average of 33, suggesting a fairly valued position. However, the balance sheet is heavily leveraged (debt‑to‑equity ≈ 136%) and cash reserves are modest relative to debt, flagging financial risk despite a sustainable dividend payout of 28% and a 0.97% yield.
Overall, the combination of low beta (0.44), high 30‑day volatility (≈48%), and positive earnings momentum paints a picture of a stock with upside potential but notable leverage‑related risk, warranting a measured, growth‑value blend stance.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price near technical support with upside to ¥5,407
  • Recent earnings beat and FY25 profit outlook upgrade
  • Low beta reducing market‑wide volatility exposure

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth of 14.8% and solid operating margins
  • Share buyback program supporting price appreciation
  • Fair valuation relative to industry peers

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • High debt‑to‑equity ratio posing balance‑sheet risk
  • Sustainable dividend with modest payout ratio
  • Diversified real‑estate portfolio offering stable cash flows

Key Metrics & Analysis

Financial Health

Revenue Growth14.80%
Profit Margin13.78%
P/E Ratio31.0
ROE9.40%
ROA2.66%
Debt/Equity136.29
P/B Ratio2.4
Industry P/E33.2

Technical Analysis

TrendBullish
RSI55.5
Support¥4,370.00
Resistance¥5,407.00
MA 20¥4,982.15
MA 50¥4,370.04
MA 200¥3,434.73
MACDBearish
VolumeStable
Fear & Greed Index80.61

Valuation

Target Price¥5,304.55
Upside/Downside7.97%
GradeFair
TypeBlend
Dividend Yield0.97%

Risk Assessment

Beta0.44
Volatility48.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.